Adipose-derived stem cells in patients with venous ulcers: Systematic review

Abstract

Objectives

Few studies have reported on the safety and durability of adipose-derived stem cells (ADSCs) to support healing in patients with venous leg ulcers (VLU). To establish if there is any evidence to support ADSC use in VLU patients, a systematic review was conducted.

Methods

A systematic review was conducted following the PRISMA guidelines. PubMed and Embase databases were searched for relevant papers. References from retrieved papers were reviewed to identify any extra eligible studies.

Results

After duplicate removal, 950 papers were screened for eligibility of which 932 were excluded based on title and abstract. Four papers were included in the final analysis (one randomised study and three non-randomised studies). 66 patients in total received ADSCs for VLU treatment. The only randomised paper reported 6-month healing rates of 75% with ADSCs compared to 50% in controls. 100% healing was achieved in one study. The remaining 2 studies reported 25% and 58% healing; however, they included patients with relatively large VLUs. Pain scores decreased after ADSCs application where reported. No serious procedure related complications were reported.

Conclusion

ADSCs may enhance ulcer healing in patients with chronic VLU and appears safe based on initial reports. Large, randomised trials are needed to definitively establish the technique’s role in VLU patients.

Keywords

Stem cells adipose tissue mesenchymal fat graft venous chronic ulcers

Get full access to this article

View all access options for this article.

References

Graham

Harrison

Nelson

, et al. Prevalence of lower-limb ulceration: a systematic review of prevalence studies. Adv Skin Wound Care 2003; 16(6): 305–316.

Brtan Romic

Brtan

Romic

, et al. Quality of Life and Perception of Disease in Patients with Chronic Leg Ulcer. Acta Clin Croat 2015; 54(3): 309–314.

Barwell

Davies

Deacon

, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet 2004; 363(9424): 1854–1859.

van Gent

Hop

van Praag

, et al.. Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial. J Vasc Surg 2006; 44(3): 563–571.

Parker

Finlayson

Edwards

. predicting the likelihood of delayed venous leg ulcer healing and recurrence: development and reliability testing of risk assessment tools. Ostomy Wound Manage 2017; 63(10): 16–33.

Phillips

Humphreys

Thayer

, et al. Cost of managing patients with venous leg ulcers. Int Wound J 2020; 17(4): 1074–1082.

Moffatt

Franks

Oldroyd

, et al. Community clinics for leg ulcers and impact on healing. BMJ 1992; 305(6866): 1389–1392.

Bello

Scriven

Hartshorne

, et al. Role of superficial venous surgery in the treatment of venous ulceration. Br J Surg 1999; 86(6): 755–759.

Barwell

Taylor

Deacon

, et al. Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers. Eur J Vasc Endovasc Surg 2000; 20(4): 363–368.

10.

Gohel

Heatley

Liu

, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med 2018; 378(22): 2105–2114.

11.

Collins

Seraj

. Diagnosis and treatment of venous ulcers. Am Fam Physician 2010; 81(8): 989–996.

12.

Moher

Liberati

Tetzlaff

, et al.. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.

13.

Oremus

Wolfson

Perrault

, et al.. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord 2001; 12(3): 232–236.

14.

Downs

Black

. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52(6): 377–384.

15.

Zollino

Campioni

Sibilla

, et al.. A phase II randomized clinical trial for the treatment of recalcitrant chronic leg ulcers using centrifuged adipose tissue containing progenitor cells. Cytotherapy 2019; 21(2): 200–211.

16.

Maslowski

Paprocka

Czyzewska-Buczynska

, et al. Autotransplantation of the adipose tissue-derived mesenchymal stromal cells in therapy of venous stasis ulcers. Arch Immunol Ther Exp (Warsz) 2020; 68(1): 5.

17.

Konstantinow

Arnold

Djabali

, et al. Therapy of ulcus cruris of venous and mixed venous arterial origin with autologous, adult, native progenitor cells from subcutaneous adipose tissue: a prospective clinical pilot study. J Eur Acad Dermatol Venereol 2017; 31(12): 2104–2118.

18.

Kavala

Turkyilmaz

. Autogenously derived regenerative cell therapy for venous leg ulcers. Arch Med Sci Atheroscler Dis 2018; 3: e156–e163.

19.

Mojallal

Lequeux

Shipkov

, et al. Improvement of skin quality after fat grafting: clinical observation and an animal study. Plast Reconstr Surg 2009; 124(3): 765–774.

20.

Simonacci

Bertozzi

Grieco

, et al.. Procedure, applications, and outcomes of autologous fat grafting. Ann Med Surg (Lond) 2017; 20: 49–60.

21.

Piccolo

. Fat grafting for treatment of burns, burn scars, and other difficult wounds. Clin Plast Surg 2015; 42(2): 263–283.

22.

Khansa

Harrison

Janis

. evidence-based scar management: how to improve results with technique and technology. Plast Reconstr Surg 2016; 138(3 Suppl): 165S–178S.

23.

Cuomo

Giardino

Nisi

, et al. Fat graft for reducing pain in chronic wounds. Wound Repair Regen 2020; 28(6): 780–788.

24.

Martinez-Santamaria

Carcamo

Garcia-Pardo

, et al. Combined adipose mesenchymal stromal cell advanced therapy resolved a recalcitrant leg ulcer in an 85-year-old patient. Regen Med 2020; 15(9): 2053–2065.